Boditech Med and SphingoTec Announce Launch of AFIAS penKid(R) Assay for Kidney Function Diagnostics
Boditech Med and SphingoTec announce the launch of the AFIAS sphingotest® penKid® assay, a diagnostic tool designed to aid in kidney function assessment for critically ill patients. The ...
The biomarker penKid adds diagnostic value and addresses current unmet needs in the management of patients suffering from acute kidney injury. PenKid's availability on Boditech's global network of ...
BELLEVUE, Wash.--(BUSINESS WIRE)-- Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results